Abstract
Electrochemical biosensors provide rapid, selective, and sensitive diagnostic platforms for detecting and monitoring biochemical processes in living systems in vivo and in vitro, and have been widely applied in various fields of biology and medicine. Sorafenib is a multi-kinase inhibitor used as a standard therapy for advanced hepatocellular carcinoma (HCC). However, the molecular basis for sorafenib resistance in HCC remains elusive. Recently, we developed new protocols for an electrochemical biosensor and applied these to monitor the levels of superoxide and nitric oxide produced in HCC cells, in the presence or absence of sorafenib. We also employed electrochemical biosensor to determine the release of profiles of superoxide and nitric oxide in sorafenib-treated HCC cells under the influence of fibroblast growth factor 19 expression levels. Here we present protocols to highlight the utility of electrochemical strategies in drug and gene studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gao L, Teng Y (2016) Exploiting plug-and-play electrochemistry for drug discovery. Future Med Chem 8(5):567–577
Teng Y, Zhao H, Gao L, Zhang W, Shull AY, Shay C (2017) FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling. Cancer Res 77(22):6215–6225
Lang L, Shull AY, Teng Y (2019) Interrupting the FGF19-FGFR4 axis to therapeutically disrupt cancer progression. Curr Cancer Drug Targets 19(1):17–25
Zhao X, Xu F, Dominguez NP, Xiong Y, Xiong Z, Peng H et al (2018) FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression. Mol Carcinog 57(11):1616–1625
Lang L, Teng Y (2019) Fibroblast growth factor receptor 4 targeting in cancer: new insights into mechanisms and therapeutic strategies. Cell 8(1):pii: E31. https://doi.org/10.3390/cells8010031
Gao L, Wang X, Tang Y, Huang S, Hu CA, Teng Y (2017) FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib. J Exp Clin Cancer Res 36(1):8. https://doi.org/10.1186/s13046-016-0478-9
Gao L, Shay C, Lv F, Wang X, Teng Y (2018) Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells—a short report. Cell Oncol (Dordr) 41(1):85–91
Acknowledgments
This research was supported by NIH grant R03DE028387 and R01DE028351 (to Y.T.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gao, L., Teng, Y. (2020). Exploiting Plug-and-Play Electrochemical Biosensors to Determine the Role of FGF19 in Sorafenib-Mediated Superoxide and Nitric Oxide Production in Hepatocellular Carcinoma Cells. In: Guest, P. (eds) Clinical and Preclinical Models for Maximizing Healthspan. Methods in Molecular Biology, vol 2138. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0471-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0471-7_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0470-0
Online ISBN: 978-1-0716-0471-7
eBook Packages: Springer Protocols